Pfizer Inc (PFE)
25.63
+0.50
(+1.99%)
USD |
NYSE |
Nov 22, 16:00
25.63
0.00 (0.00%)
After-Hours: 18:19
Pfizer Free Cash Flow: 8.227B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.227B |
| June 30, 2024 | 4.81B |
| March 31, 2024 | 5.106B |
| December 31, 2023 | 4.793B |
| September 30, 2023 | 8.178B |
| June 30, 2023 | 10.66B |
| March 31, 2023 | 20.21B |
| December 31, 2022 | 26.03B |
| September 30, 2022 | 23.36B |
| June 30, 2022 | 28.44B |
| March 31, 2022 | 31.78B |
| December 31, 2021 | 29.87B |
| September 30, 2021 | 29.77B |
| June 30, 2021 | 21.14B |
| March 31, 2021 | 13.48B |
| December 31, 2020 | 12.18B |
| September 30, 2020 | 10.96B |
| June 30, 2020 | 13.22B |
| March 31, 2020 | 12.15B |
| December 31, 2019 | 10.54B |
| September 30, 2019 | 10.96B |
| June 30, 2019 | 11.81B |
| March 31, 2019 | 13.21B |
| December 31, 2018 | 13.69B |
| September 30, 2018 | 16.00B |
| Date | Value |
|---|---|
| June 30, 2018 | 15.60B |
| March 31, 2018 | 14.92B |
| December 31, 2017 | 14.58B |
| September 30, 2017 | 13.54B |
| June 30, 2017 | 13.55B |
| March 31, 2017 | 13.91B |
| December 31, 2016 | 14.19B |
| September 30, 2016 | 13.16B |
| June 30, 2016 | 13.55B |
| March 31, 2016 | 14.26B |
| December 31, 2015 | 13.19B |
| September 30, 2015 | 14.16B |
| June 30, 2015 | 13.37B |
| March 31, 2015 | 13.30B |
| December 31, 2014 | 15.50B |
| September 30, 2014 | 15.52B |
| June 30, 2014 | 17.19B |
| March 31, 2014 | 16.88B |
| December 31, 2013 | 16.22B |
| September 30, 2013 | 15.36B |
| June 30, 2013 | 14.50B |
| March 31, 2013 | 14.78B |
| December 31, 2012 | 15.33B |
| September 30, 2012 | 15.41B |
| June 30, 2012 | 14.67B |
Free Cash Flow Range, Past 5 Years
4.793B
Minimum
Dec 2023
31.78B
Maximum
Mar 2022
16.24B
Average
12.70B
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.714B |
| Cash from Investing (Quarterly) | -2.057B |
| Cash from Financing (Quarterly) | -4.636B |
| Free Cash Flow Per Share (Quarterly) | 1.063 |
| Free Cash Flow to Equity (Quarterly) | 8.123B |
| Free Cash Flow to Firm (Quarterly) | 6.697B |
| Free Cash Flow Yield | 5.65% |